Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities
29. Juli 2024 07:00 ET
|
Tilray Brands, Inc.
NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and...
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
24. Juli 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical receives second approval for new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10 or Tilray Solução Oral THC10:CBD10.
Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations
22. Juli 2024 07:00 ET
|
Tilray Brands, Inc.
New cannabis cultivation license allows Aphria RX to cultivate a range of higher quality medical cannabis produced in Germany.